Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern-Reference-Cited by-同舟云学术

Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern

Published:2020-02 Issue:2 Volume:19 Page:102455
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Matas-García Ana,Milisenda José C.,Selva-O'Callaghan Albert,Prieto-González Sergio,Padrosa Joan,Cabrera Carlos,Reguart Noemi,Castrejón Natalia,Solé Manel,Ros Javier,Trallero-Araguas Ernesto,Antoniol Maria Noelia,Vila-Pijoan Gemma,Grau Josep María

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference18 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

3. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N Engl J Med,2016

4. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy;Zimmer;Eur J Cancer,2016

5. Immune checkpoint inhibitor-associated myocarditis;Ganatra;Oncologist,2018

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor-induced Myositis;Rheumatic Disease Clinics of North America;2024-05

2. Treatment of Myositis Associated With Immune Checkpoint Inhibitors;Current Treatment Options in Rheumatology;2023-11-02

3. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature;Autoimmunity Reviews;2023-08

4. Paraneoplastic Necrotizing Myopathy Associated With Metastatic Colon Cancer: A Case Report;Cureus;2023-03-22

5. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis;Annals of the Rheumatic Diseases;2023-02-17